NIH PAR · NIGMS · P30
PAR-27-068: Limited Competition: NIGMS Mature Synchrotron Resources (MSR) for Structural Biology (P30 - Clinical Trial Not Allowed)
Reviewed by Dr. Meng ZhaoLast reviewed October 16, 2026Data refreshed October 16, 2026Editorial standards
This Notice of Funding Opportunity (NOFO) supports "mature" resources at synchrotron facilities that provide user access to X-ray beamlines for static and dynamic imaging of biological systems ranging from molecules to organs. "Mature" refers to the techniques made available at the resource beamlines, which must be well established and provide utility to the communities they serve without requiring significant novel technology development. Applications may only request support for existing synchrotron resources that are currently supported by NIGMS funding. The facility is expected to be maintained or upgraded to current best practices, make its capabilities and availability known to the…
- NOFO number
- PAR-27-068
- Type
- PAR
- Activity code
- P30
- Primary institute
- NIGMS · National Institute of General Medical Sciences
- Clinical trials
- Not Allowed
- Posted
- Aug 31, 2026
- Opens
- Sep 2, 2026
- Expires
- Oct 3, 2028
PAR-27-068 due dates
2 application due dates remain before the NOFO expires. Dates marked * are NIH standard due dates. Check the related notices below for changes NIH made after posting.
| New | Renewal / Resubmission / Revision (as allowed) | AIDS - New/Renewal/Resubmission/Revision, as allowed | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
|---|---|---|---|---|---|
| October 02, 2026 | October 02, 2026 | Not Applicable | March 2027 | May 2027 | July 2027 |
| October 01, 2027 | October 01, 2027 | Not Applicable | March 2028 | May 2028 | July 2028 |
| October 02, 2028 | October 02, 2028 | Not Applicable | March 2029 | May 2029 | July 2029 |
What its predecessor PAR-22-166 funded
PAR-27-068 reissues PAR-22-166. Until awards appear under the new number, its funding history is the best guide to who wins under this program: 5 projects and $45.0M in FY2022–FY2026.
Projects funded
5
Distinct projects, FY2022–FY2026
New awards
0
Type 1 (new project) award records
NIH funding
$45.0M
Award dollars under PAR-22-166, FY2022–FY2026
Funding by fiscal year
| Fiscal year | Award records | New awards | Funding |
|---|---|---|---|
| FY2022 | 0 | 0 | $0 |
| FY2023 | 0 | 0 | $0 |
| FY2024 | 2 | 0 | $8.3M |
| FY2025 | 4 | 0 | $17.2M |
| FY2026 | 5 | 0 | $19.4M |
Institutions with the most funding
- Brookhaven Science Assoc-Brookhaven Lab$13.8M · 1 project
- Cornell University$10.6M · 1 project
- Uchicago Argonne, LLC$9.1M · 1 project
- Stanford University$8.8M · 1 project
- Illinois Institute of Technology$2.6M · 1 project
Funding institutes
- NIGMS$45.0M · 11
Activity codes funded
- P3011 records
FY2026 closed on September 30, 2026, but NIH keeps posting that year's awards to RePORTER for several weeks. FY2026 figures reflect records available on October 16, 2026 and may rise slightly at the next refresh.
Participating institutes
2 NIH institutes and offices take applications under PAR-27-068. Contact the program officer at the institute that fits your research before applying.
- NIGMS · National Institute of General Medical Sciences
- none
Related notices
Jan 23, 2026 · NOT-OD-26-031
NIH Pause on New Submissions to the NIH Human Embryonic Stem Cell Registry and Request for Information on Reducing Reliance on Human Embryonic Stem Cells in NIH-Supported Research.
Award terms
- Application types allowed
- New Renewal Revision The OER Glossary and the How to Apply - Application Guide provides details on these application types. Only those application types listed here are allowed for this NOFO.
- Award budget
- Application budgets are not limited, but need to reflect the actual needs of the proposed project.
- Project period
- Support for up to five years may be requested. NIH grants policies as described in the NIH Grants Policy Statement will apply to the applications submitted and awards made from this NOFO.
- Funds available and number of awards
- The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
Summarized from the NOFO text; the full NOFO governs eligibility, budget, and review.
Related NOFOs
- Reissue of PAR-22-166.
Other open NOFOs for P30
- PAR-27-054Limited Competition: Centers of Biomedical Research Excellence: Development Phase (COBRE-D) (P30 - Clinical Trial Not Allowed)NIGMS · next due Jan 25, 2027
- PAR-27-055Limited Competition: Centers of Biomedical Research Excellence: Expansion/Sustainability Phases (COBRE-E/S) (P30 - Clinical Trial Not Allowed)NIGMS · next due Jan 25, 2027
- PAR-27-056Limited Competition: Institutional Development Award (IDeA) for Clinical & Translational Research (CTR) (P30 - CT Optional)NIGMS · next due Jan 28, 2027
- RFA-DK-27-120Nutrition Obesity Research Centers (NORCs) (P30 Clinical Trial Optional)NIDDK · next due Oct 20, 2026
- PAR-25-444Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)NCI · next due Jan 25, 2027
- RFA-DK-26-310Diabetes Research Centers (P30 Clinical Trial Optional)NIDDK · next due Jan 27, 2027
About this page
GotGrant gathers the NOFO, its participation and change notices, and its NOSIs from the NIH Guide for Grants and Contracts, and counts funded projects from NIH RePORTER by the opportunity number each award was made under. Data refreshed October 16, 2026; the NIH Guide is the authoritative source. See our data methodology.